Biology of T lymphocytes

Rheumatic Disease Clinics of North America

Volumn 30, Issue 1, 2004, Pages 135-157

  Vallejo, Abbe N ^a   Davila, Eduardo ^a   Weyand, Cornelia M ^a   Goronzy, Jörg J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANTIGEN RECOGNITION; ASTHMA; AUTOIMMUNITY; CELL AGING; CELL LINEAGE; CELL MATURATION; CELLULAR IMMUNITY; CROHN DISEASE; CYTOLOGY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HELPER CELL; HUMAN; INFLUENZA; INFLUENZA VACCINATION; LYMPHOCYTE PROLIFERATION; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 1242300055     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-857X(03)00114-5     Document Type: Review

References (89)

1. Clevers H., Alarcon B., Wileman T.et al. The T cell receptor/CD3 complex: a dynamic protein ensemble. Annu Rev Immunol. 6:1988;629-662.
2. Spits H. Development of alphabeta T cells in the human thymus. Nat Rev Immunol. 2:2002;760-772.
3. Haas W., Pereira P., Tonegawa S. Gamma/delta cells. Annu Rev Immunol. 11:1993;637-685.
4. Carding S.R., Egan P.J. Gammadelta T cells: functional plasticity and heterogeneity. Nat Rev Immunol. 2:2002;336-345.
5. Lefrancois L., Masopust D. T cell immunity in lymphoid and non-lymphoid tissues. Curr Opin Immunol. 14:2002;503-508.
6. Hiltbold E.M., Roche P.A. Trafficking of MHC class II molecules in the late secretory pathway. Curr Opin Immunol. 14:2002;30-35.
7. Brocke P., Garbi N., Momburg F.et al. HLA-DM, HLA-DO and tapasin: functional similarities and differences. Curr Opin Immunol. 14:2002;22-29.
8. Pamer E., Cresswell P. Mechanisms of MHC class I-restricted antigen processing. Annu Rev Immunol. 16:1998;323-358.
9. Bjorkman P.J. MHC restriction in three dimensions: a view of T cell receptor/ligand interactions. Cell. 89:1997;167-170.
10. Gellert M. V(D)J recombination: RAG proteins, repair factors, and regulation. Annu Rev Biochem. 71:2002;101-132.
11. Jorgensen J.L., Reay P.A., Ehrich E.W.et al. Molecular components of T-cell recognition. Annu Rev Immunol. 10:1992;835-873.
12. Hirose J., Kouro T., Igarashi H.et al. A developing picture of lymphopoiesis in bone marrow. Immunol Rev. 189:2002;28-40.
13. Radtke F., Wilson A., Ernst B.et al. The role of notch signaling during hematopoietic lineage commitment. Immunol Rev. 187:2002;65-74.
14. Starr T.K., Jameson S.C., Hogquist K.A. Positive and negative selection of T cells. Annu Rev Immunol. 21:2003;139-176.
15. Germain R.N. T-cell development and the CD4-CD8 lineage decision. Nat Rev Immunol. 2:2002;309-322.
16. Legname G., Seddon B., Lovatt M.et al. Inducible expression of a p56Lck transgene reveals a central role for Lck in the differentiation of CD4 SP thymocytes. Immunity. 12:2000;537-546.
17. Hernandez-Hoyos G., Sohn S.J., Rothenberg E.V.et al. Lck activity controls CD4/CD8 T-cell lineage commitment. Immunity. 12:2000;313-322.
18. Corbella P., Moskophidis D., Spanopoulou E.et al. Functional commitment to helper T-cell lineage precedes positive selection and is independent of T-cell receptor MHC specificity. Immunity. 1:1994;269-276.
19. + helper T cells in class II major histocompatibility complex mutant mice. J Exp Med. 179:1994;1997-2004.
20. Paterson R.K., Burkly L.C., Kurahara D.K.et al. Thymic development in human CD4 transgenic mice. Positive selection occurs after commitment to the CD8 lineage. J Immunol. 153:1994;3491-3503.
21. Leung R.K., Thomson K., Gallimore A.et al. Deletion of the CD4 silencer element supports a stochastic mechanism of thymocyte lineage commitment. Nat Immunol. 2:2001;1167-1173.
22. Gordon S. Pattern recognition receptors: doubling up for the innate immune response. Cell. 111:2002;927-930.
23. Barton G.M., Medzhitov R. Toll-like receptors and their ligands. Curr Top Microbiol Immunol. 270:2002;81-92.
24. Schmitz G., Orso E. CD14 signalling in lipid rafts: new ligands and co-receptors. Curr Opin Lipidol. 13:2002;513-521.
25. Krummel M.F., Davis M.M. Dynamics of the immunological synapse: finding, establishing and solidifying a connection. Curr Opin Immunol. 14:2002;66-74.
26. Rachmilewitz J., Lanzavecchia A. A temporal and spatial summation model for T-cell activation: signal integration and antigen decoding. Trends Immunol. 23:2002;592-595.
27. Kane L.P., Lin J., Weiss A. Signal transduction by the TCR for antigen. Curr Opin Immunol. 12:2000;242-249.
28. Clements J.L., Boerth N.J., Lee J.R.et al. Integration of T cell receptor-dependent signaling pathways by adapter proteins. Annu Rev Immunol. 17:1999;89-108.
29. Alegre M.L., Frauwirth K.A., Thompson C.B. T-cell regulation by CD28 and CTLA-4. Nat Rev Immunol. 1:2001;220-228.
30. Saloman B., Bluestone J.A. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol. 19:2001;225-252.
31. Bromley S.K., Iaboni A., Davis S.J.et al. The immunological synapse and CD28-CD80 interactions. Nat Immunol. 2:2001;1159-1166.
32. Egen J.G., Allison J.P. Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength. Immunity. 16:2002;23-35.
33. Baumann S., Krueger A., Kirchhoff S.et al. Regulation of T cell apoptosis during the immune response. Curr Mol Med. 2:2002;257-272.
34. Van Parijs L., Refaeli Y., Lord J.D.et al. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death. Immunity. 11:1999;281-288.
35. van Kooten C., Banchereau J. CD40-CD40 ligand. J Leukoc Biol. 67:2000;2-17.
36. Romagnani S. The Th1/Th2 paradigm. Immunol Today. 18:1997;263-266.
37. Moser M., Murphy K.M. Dendritic cell regulation of TH1-TH2 development. Nat Immunol. 1:2000;199-205.
38. Murphy K.M., Reiner S.L. The lineage decisions of helper T cells. Nat Rev Immunol. 2:2002;933-944.
39. Neurath M.F., Finotto S., Glimcher L.H. The role of Th1/Th2 polarization in mucosal immunity. Nat Med. 8:2002;567-573.
40. Barry M., Bleackley R.C. Cytotoxic T lymphocytes: all roads lead to death. Nat Rev Immunol. 2:2002;401-409.
41. Trapani J.A., Smyth M.J. Functional significance of the perforin/ granzyme cell death pathway. Nat Rev Immunol. 2:2002;735-747.
42. Shresta S., Graubert T.A., Thomas D.A.et al. Granzyme A initiates an alternative pathway for granule-mediated apoptosis. Immunity. 10:1999;595-605.
43. Motyka B., Korbutt G., Pinkoski M.J.et al. Mannose-6-phosphate/insulin- like growth factor II receptor is a death receptor for granzyme B during cytotoxic T-cell induced apoptosis. Cell. 103:2000;491-500.
44. Browne K.A., Blink E., Sutton V.R.et al. Cytosolic delivery of granzyme B by bacterial toxins: evidence that endosomal disruption in addition to transmembrane pore formation, is an important function of perforin. Mol Cell Biol. 19:1999;8604-8615.
45. Liblau R.S., Wong F.S., Mars L.T.et al. Autoreactive CD8 T cells in organ-specific autoimmunity: emerging targets for therapeutic intervention. Immunity. 17:2002;1-6.
46. Jones D.H., Kong Y.Y., Penninger J.M. Role of RANKL and RANK in bone loss and arthritis. Ann Rheum Dis. 61(Suppl 2):2002;32-39.
47. Lieberman J., Shankar P., Manjunath N.et al. Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. Blood. 98:2001;1667-1677.
48. Kaech S.M., Wherry E.J., Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol. 2:2002;251-262.
49. Sprent J., Surh C.D. T cell memory. Annu Rev Immunol. 20:2002;551-579.
50. Jameson S.C. Maintaining the norm: T-cell homeostasis. Nat Rev Immunol. 2:2002;547-556.
51. Geginat J., Lanzavecchia A., Sallusto F. Proliferation and differentiation potential of human CD8 + memory T-cell subsets in response to antigen or homeostatic cytokines. Blood. 101:2003;4620-4626.
52. Baron V., Bouneaud C., Cumano A.et al. The repertoires of circulating human CD8(+) central and effector memory T cell subsets are largely distinct. Immunity. 18:2003;193-204.
53. Burnet F.M. The clonal selection theory of acquired immunity. 1959;Vanderbilt University Press, Nashville (TN).
54. Anderton S.M., Wraith D.C. Selection and fine-tuning of the autoimmune T-cell repertoire. Nat Rev Immunol. 2:2002;487-498.
55. Matzinger P. The danger model: a renewed sense of self. Science. 296:2002;301-305.
56. Lipscomb M.F., Masten B.J. Dendritic cells: immune regulators in health and disease. Physiol Rev. 82:2002;97-130.
57. Moseley P. Stress proteins and the immune response. Immunopharmacology. 48:2000;299-302.
58. Stuart L.M., Lucas M., Simpson C.et al. Inhibitory effects of apoptotic cell ingestion upon endotoxin-driven myeloid dendritic cell maturation. J Immunol. 168:2002;1627-1635.
59. Ren Y., Savill J. Apoptosis: the importance of being eaten. Cell Death Differ. 5:1998;563-568.
60. Wucherpfennig K.W. Mechanisms for the induction of autoimmunity by infectious agents. J Clin Invest. 108:2001;1097-1104.
61. Walker L.S., Abbas A.K. The enemy within: keeping self-reactive T cells at bay in the periphery. Nat Rev Immunol. 2:2002;11-19.
62. Lafaille J.J. The role of helper T cell subsets in autoimmune diseases. Cytokine Growth Factor Rev. 9:1998;139-151.
63. Fischer A., Rieux-Laucat F., Le Deist F. Autoimmune lymphoproliferative syndromes (ALPS): models for the study of peripheral tolerance. Rev Immunogenet. 2:2000;52-60.
64. Shevach E.M. CD4+CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol. 2:2002;389-400.
65. Cortesini R., LeMaoult J., Ciubotariu R.et al. CD8+. Immunol Rev. 182:2001;201-206.
66. Steinman R.M., Hawiger D., Nussenzweig M.C. Tolerogenic dendritic cells. Annu Rev Immunol. 21:2003;685-711.
67. Hackstein H., Morelli A.E., Thomson A.W. Designer dendritic cells for tolerance induction: guided not misguided missiles. Trends Immunol. 22:2001;437-442.
68. Effros R.B., Pawelec G. Replicative senescence of T cells: does the Hayflick Limit lead to immune exhaustion? Immunol Today. 18:1997;450-454.
69. Fry T.J., Mackall C.L. Current concepts of thymic aging. Springer Semin Immunopathol. 24:2002;7-22.
70. Richardson B.C. Role of DNA methylation in the regulation of cell function: autoimmunity, aging and cancer. J Nutr. 132:2002;2401S-2405S.
71. Posnett D.N., Sinha R., Kabak S.et al. Clonal populations of T cells in normal elderly humans: the T cell equivalent to "benign monoclonal gammapathy. J Exp Med. 179:1994;609-618.
72. Vallejo A.N., Nestel A.R., Schirmer M.et al. Aging-related deficiency of CD28 expression in CD4 + T cells is associated with the loss of gene-specific nuclear factor binding activity. J Biol Chem. 273:1998;8119-8129.
73. Goronzy J.J., Fulbright J.W., Crowson C.S.et al. Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol. 75:2001;12182-12187.
74. Saurwein-Teissl M., Lung T.L., Marx F.et al. Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol. 168:2002;5893-5899.
75. Martens P.B., Goronzy J.J., Schaid D.et al. Expansion of unusual CD4 + T cells in severe rheumatoid arthritis. Arthritis Rheum. 40:1997;1106-1114.
76. Moosig F., Csernok E., Wang G.et al. Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells. Clin Exp Immunol. 114:1998;113-118.
77. Schirmer M., Goldberger C., Wurzner R.et al. Circulating cytotoxic CD8(+) CD28(-) T cells in ankylosing spondylitis. Arthritis Res. 4:2002;71-76.
78. Liuzzo G., Kopecky S.L., Frye R.L.et al. Perturbation of the T-cell repertoire in patients with unstable angina. Circulation. 100:1999;2135-2139.
79. Dutra W.O., Martins-Filho O.A., Cancado J.R.et al. Chagasic patients lack CD28 expression on many of their circulating T lymphocytes. Scand J Immunol. 43:1996;88-93.
80. Vallejo A.N., Weyand C.M., Goronzy J.J. Functional disruption of the CD28 gene transcriptional initiator in senescent T cells. J Biol Chem. 276:2001;2565-2570.
81. Bryl E., Vallejo A.N., Weyand C.M.et al. Down-regulation of CD28 expression by TNF-alpha. J Immunol. 167:2001;3231-3238.
82. Campisi J. Cancer, aging and cellular senescence. In Vivo. 14:2000;183-188.
83. Monteiro J., Batliwalla F., Ostrer H.et al. Shortened telomeres in clonally expanded CD28-CD8+ T cells imply a replicative history that is distinct from their CD28+CD8+ counterparts. J Immunol. 156:1996;3587-3590.
84. null T cells are associated with defects in apoptotic pathways. J Immunol. 165:2000;6301-6307.
85. Weyand C.M., Brandes J.C., Schmidt D.et al. Functional properties of CD4 +. Mech Ageing Dev. 102:1998;131-147.
86. Snyder M.R., Lucas M., Vivier E.et al. Selective activation of the c-Jun NH2-terminal protein kinase signaling pathway by stimulatory KIR in the absence of KARAP/DAP12 in CD4 + T cells. J Exp Med. 197:2003;437-449.
87. Vallejo A.N., Brandes J.C., Weyand C.M.et al. Modulation of CD28 expression: distinct regulatory pathways during activation and replicative senescence. J Immunol. 162:1999;6572-6579.
88. Vallejo A.N., Bryl E., Klarskov K.et al. Molecular basis for the loss of CD28 expression in senescent T cells. J Biol Chem. 277:2002;46940-46949.
89. Warrington K.J., Vallejo A.N., Weyand C.M.et al. CD28 loss in senescent CD4 + T cells: reversal by interleukin-12 stimulation. Blood. 101:2002;3543-3549.